Wilmington, Delaware–(Newsfile Corp. – January 10, 2025) – Rigrodsky Law, P.A. is investigating Akoya Biosciences, Inc. (“Akoya”) (NASDAQ: AKYA) regarding possible breaches of fiduciary duties and other violations of law related to Akoya’s agreement to be acquired by Quanterix (NASDAQ:) Corporation (“Quanterix”). Under the terms of the agreement, Akoya shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-akoya-biosciences-inc.
To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email info@rl-legal.com.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/236746
